Comparing Lignocaine and Bupivacaine Injections for Reducing Postpartum Perineal Pain After Vaginal Delivery with Episiotomy in First-Time Mothers

What this Trial Is About

Researchers are evaluating the effects and safety of lignocaine versus bupivacaine infiltration for managing postpartum perineal pain after vaginal delivery with episiotomy in first-time mothers. This study aims to compare these two local anesthetics to understand how they relieve pain caused by episiotomy, a common procedure that can cause both short- and long-term discomfort and mobility issues after childbirth. The trial involves two groups receiving perineal infiltration of either 100 mg lignocaine or 20 mg bupivacaine, injected slowly at multiple points around the episiotomy site before repair. Both drugs are administered by carefully injecting into all tissue layers vagina, muscle, and skin to target pain effectively. The study is randomized and double-blind to fairly compare the treatments. Participants will be assessed primarily for pain levels six hours after the procedure. Additional evaluations include the time until first need for pain relief, total pain medication used within 12 hours, incidence of complications, and time taken to begin walking post-delivery. The study lasts from March to September 2024, with careful monitoring of safety and pain outcomes to understand the impact of each anesthetic.

Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae